Pet microchips carry an extremely low risk of causing cancer. Tumors at microchip implantation sites have been documented in a small number of animals, but the incidence is roughly 1% in laboratory rodents and far lower in dogs and cats. Every major veterinary organization considers the benefits of microchipping to far outweigh this risk.
What the Evidence Actually Shows
The concern isn’t baseless. Tumors called fibrosarcomas and liposarcomas have been found at microchip implantation sites in dogs, cats, and laboratory rodents. A 2024 case report in the Journal of Feline Medicine and Surgery described a 14-year-old cat that developed a fibrosarcoma right next to its identification microchip, the first documented case in a cat. Similar tumors had previously been reported in dogs.
In long-term rodent studies, microchip-associated tumors appeared at an incidence of approximately 1%. That sounds alarming until you consider the context: lab rodents are already prone to developing tumors at virtually any implantation site, regardless of what’s implanted. The rate in pet dogs and cats appears to be dramatically lower, though no large-scale study has pinned down an exact number. After hundreds of millions of pets have been microchipped worldwide over several decades, only a handful of tumor cases have been published in the veterinary literature.
Why Foreign Objects Can Trigger Tumors
The mechanism behind these rare cancers isn’t unique to microchips. Any solid foreign object implanted under the skin can, in theory, provoke a chain of cellular changes that leads to cancer. This phenomenon, called foreign body carcinogenesis, has been studied since the mid-20th century. Research on implanted polymer films in mice showed that the shape and surface characteristics of an implant matter more than its chemical composition. Large, smooth, non-perforated surfaces triggered sarcomas in a high percentage of rodents, while perforated or textured versions of the same material rarely did.
The process works in stages. First, the body surrounds the foreign object with a capsule of inflammatory and connective tissue cells. Over months or years, chronic inflammation at that site can cause DNA damage in the surrounding cells. In a small fraction of cases, those damaged cells become cancerous. Pet microchips are encased in biocompatible glass specifically designed to minimize tissue reaction, which is one reason the real-world tumor rate is so low. But no implanted object can eliminate the inflammatory response entirely.
How the Risk Compares to the Benefit
The American Veterinary Medical Association explicitly recommends against removing microchips over cancer concerns. Their reasoning is twofold: the cancer risk is “very, very low,” and removing a microchip is a more invasive procedure than implanting one, potentially requiring general anesthesia and surgery.
The reunion statistics make the case clearly. Microchipped pets that end up in shelters are up to 21 times more likely to be returned to their owners than pets without chips. A large national study in the U.S. found that microchipping boosted owner recovery rates from 22% to 52% for dogs and from 2% to 39% for cats. For cats especially, a microchip can be the difference between coming home and never being found.
What to Watch For
If your pet is microchipped, there’s no reason to panic, but it’s reasonable to keep an eye on the implant site. Microchips are typically injected between the shoulder blades. During routine petting or grooming, you can feel for the small, rice-grain-sized chip under the skin. What you’re looking for is any new lump or mass growing near that spot, particularly one that’s firm, seems attached to deeper tissue, or grows rapidly over weeks. A small, mobile bump right after implantation is normal and usually resolves on its own.
If you do notice a growing mass near the chip site, bring it to your vet’s attention. The vast majority of lumps in pets turn out to be benign fatty deposits or cysts, not sarcomas. But early detection matters for the rare cases that aren’t benign, since fibrosarcomas are aggressive tumors that can metastasize if left untreated.
Do Human Microchips Pose the Same Risk?
A small but growing number of people have voluntarily implanted microchips for keyless entry, digital payments, or identification. These chips use similar biocompatible glass casings and are comparable in size to pet microchips. The foreign body carcinogenesis mechanism is theoretically the same in humans, but no cases of microchip-associated cancer have been reported in people. The number of implanted humans is still very small compared to the pet population, and the chips haven’t been in place long enough to draw firm conclusions about long-term risk. The rodent and pet data suggest any risk would be very low, but it isn’t zero.